The Food and Drug Administration (FDA) said in multiple notices that numerous over-the-counter medications, including Bayer aspirin, Tylenol, Advil, Alka Seltzer, and more, are under recall by the agency due to conditions in a Minnesota distribution center. Full article below The Food and Drug Administration (FDA) said in multiple notices that numerous over-the-counter medications, including Bayer aspirin, Tylenol, Advil, Alka Seltzer, and more, are under recall by the agency due to conditions in a Minnesota distribution center. Minneapolis-based Gold Star Distribution Inc. issued recalls for certain lots of Advil, Bayer aspirin, Claritin antihistamine, DayQuil Cold & Flu, Liquid DayQuil, Liquid NyQuil, NyQuil Cold & Flu, Children’s NyQuil Cold & Flu, Pepto Bismol, Pepcid Complete, Tylenol, Halls Cough Drops, and Tums. A full list of the more than 800 items, including human food products, pet food, and cosmetics under recall by Gold Star can be found on a document posted on the FDA’s website. The notices all said that the recalls were initiated over “insanitary conditions, including rodent exposure/activity in their distribution center.” While the recalls of the product are ongoing, Gold Star initiated the action on Dec. 26, 2025, and the FDA posted the notices on Jan. 14. In the notices, the FDA said that the recalls were upgraded to Class II, or second out of a three-tier system, which the agency defines as a “situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” Other products, which are not over-the-counter medications, that were distributed by Gold Star are also under recall, according to a slew of notices posted by the agency on Jan. 14.
FDA issues big recall the agency due to conditions in a Minnesota distribution center.
🧐 Mental/Physical Health 🦠
Bassam Abu-Samrah is the CEO and owner of Gold Star Distribution Inc., a wholesale distributor based in Minneapolis, Minnesota. He has led the company since its founding in 1997, operating under the name B2 Up USA. The company is located at 1000 Humboldt Ave N, Minneapolis, MN 55411, and specializes in non-durable goods, including confectionery and snack products.
Contact: (612) 617-9800
Website: www.goldstardist.com
Company Revenue: Estimated at $1.9 million annually
Employees: Approximately 4
Education: Winona State University (attended 1984–1987)
Bassam Abu-Samrah has been involved in legal matters related to the company, including a 2021 trademark lawsuit filed by Global Commodities, Inc. Additionally, in 2018, the FDA issued a warning letter to him regarding unsanitary conditions at the company’s warehouse, including rodent infestations and contamination risks.